Feb 18, 2020   SOURCE: PR NewsWire

Global Vagus Nerve Stimulators Industry Analysis, 2019-2020 & 2025: Products, Applications, End-users, Regions, Players

DUBLIN, Feb. 18, 2020 /PRNewswire/ -- The "Vagus Nerve Stimulators Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The market is expected to grow in the near future during the forecast period. Whereas, North America and Europe are expected to be the major regions generating revenue for the market.

The incidence and prevalence rate of epilepsy is rising significantly across the globe. As per the Epilepsy Foundation, one in 26 people develops epilepsy at some point in their lifetime. As per the Institute for Health Metrics and Evaluation the prevalence of epilepsy has reached to more than 27.3 million in 2017 from about 25.3 million in 2013.

No significant US FDA approval for the Vagus Nerve Stimulator has been recorded in 2019. In October 2018, Electrocore has received the US FDA approval for its non-invasive vagus nerve stimulator therapy device to prevent cluster headache as well. It is a self-administered therapy using the GammaCore device. To use the device, the patient had to apply a conductive gel on the side of the neck and then given a mild electrical stimulation through the skin. In October 2017, the US FDA Approved Vagus Nerve Stimulation Therapy system which has an implantable generator (SenTivaTM) and the Therapy Programming System for the treatment of epilepsy.

This report covers:

    --  Comprehensive research methodology of the Vagus Nerve Stimulators
        market.
    --  A detailed and extensive market overview with key analyst insights.
    --  An exhaustive analysis of macro and micro factors influencing the market
        guided by key recommendations.
    --  Analysis of regional regulations and other government policies impacting
        the Vagus Nerve Stimulators market.
    --  Insights about market determinants which are stimulating the Vagus Nerve
        Stimulators market.
    --  Detailed and extensive market segments with regional distribution of
        forecasted revenues.
    --  Extensive profiles and recent developments of market players.

Key Topics Covered

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Vagus Nerve Stimulators Market by Product
5.1.1. Implantable
5.1.2. External
5.2. Global Vagus Nerve Stimulators Market by Applications
5.2.1. Epilepsy
5.2.2. Depression
5.2.3. Others (Migraine)
5.3. Global Vagus Nerve Stimulators Market by End-users
5.3.1. Hospitals and Clinics
5.3.2. Research Institutes

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Aleva Neurotherapeutics SA
7.2. BioControl Medical
7.3. Bioness Inc.
7.4. Boston Scientific Corp.
7.5. ElectroCore LLC
7.6. EnteroMedics Inc.
7.7. LivaNova PLC
7.8. Medtronic PLC
7.9. NeuroPace Inc.
7.10. Nevro Corp.

For more information about this report visit https://www.researchandmarkets.com/r/ps2cyl

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-vagus-nerve-stimulators-industry-analysis-2019-2020--2025-products-applications-end-users-regions-players-301006508.html

SOURCE Research and Markets